Ken Griffin Biolife Solutions Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Biolife Solutions Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 8,200 shares of BLFS stock, worth $224,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,200

Previous 11,600 29.31%

Holding current value

$224,598

Previous $248,000 17.34%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.19 - $26.52 $3.22 Million - $4.45 Million	167,686 Added 171.44%	265,497 $6.65 Million
Q2 2024 Aug 14, 2024	SELL	$15.14 - $22.99 $7.03 Million - $10.7 Million	-464,235 Reduced 82.6%	97,811 $2.1 Million
Q1 2024 May 15, 2024	BUY	$15.35 - $18.82 $93,404 - $114,519	6,085 Added 1.09%	562,046 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$8.99 - $16.86 $476,487 - $893,613	-53,002 Reduced 8.7%	555,961 $9.03 Million
Q3 2023 Nov 14, 2023	BUY	$10.81 - $22.96 $6.58 Million - $14 Million	608,788 Added 347878.88%	608,963 $8.41 Million
Q2 2023 Aug 14, 2023	SELL	$17.19 - $24.34 $538,717 - $762,791	-31,339 Reduced 99.44%	175 $3,000
Q1 2023 May 15, 2023	SELL	$17.67 - $26.07 $354,230 - $522,625	-20,047 Reduced 38.88%	31,514 $685,000
Q4 2022 Feb 14, 2023	BUY	$16.95 - $25.07 $524,907 - $776,367	30,968 Added 150.38%	51,561 $938,000
Q3 2022 Nov 14, 2022	SELL	$14.64 - $26.7 $633,209 - $1.15 Million	-43,252 Reduced 67.75%	20,593 $468,000
Q2 2022 Aug 15, 2022	SELL	$10.54 - $24.2 $737,452 - $1.69 Million	-69,967 Reduced 52.29%	63,845 $881,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $514,027 - $921,100	24,701 Added 22.64%	133,812 $3.04 Million
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $2.06 Million - $3.65 Million	62,364 Added 133.41%	109,111 $4.07 Million
Q3 2021 Nov 15, 2021	SELL	$42.03 - $60.5 $599,642 - $863,153	-14,267 Reduced 23.38%	46,747 $1.98 Million
Q1 2021 May 17, 2021	BUY	$32.95 - $44.24 $735,575 - $987,613	22,324 Added 57.7%	61,014 $2.2 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $45.75 $1.06 Million - $1.77 Million	38,690 New	38,690 $1.54 Million
Q3 2020 Nov 16, 2020	SELL	$16.04 - $28.94 $402,956 - $727,030	-25,122 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.2 - $17.06 $114,953 - $213,164	12,495 Added 98.95%	25,122 $411,000
Q1 2020 May 15, 2020	SELL	$8.36 - $17.03 $244,086 - $497,224	-29,197 Reduced 69.81%	12,627 $120,000
Q2 2019 Aug 14, 2019	BUY	$15.2 - $19.42 $377,492 - $482,295	24,835 Added 146.18%	41,824 $709,000
Q2 2018 Aug 10, 2018	BUY	$6.18 - $13.49 $36,746 - $80,211	5,946 Added 53.84%	16,989 $0
Q1 2018 May 11, 2018	BUY	$4.73 - $6.03 $52,233 - $66,589	11,043 New	11,043 $56,000

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account